Furthermore, in AD, the combined application of transcriptomic technologies has enabled the identification of amyloid- and tau-related transcriptional changes localized to specific cortical layers, enhancing our understanding of disease mechanisms [84]. This evidence concerns the gene MAPT and Alzheimer disease.